An mpox quadrivalent mRNA vaccine elicits sustained and protective immunity in mice against lethal vaccinia virus challenge
Assessing the long-term efficacy of MPXV vaccine candidates is crucial for the global response to the ongoing mpox epidemic. Built upon our previous study of the mpox quadrivalent mRNA vaccine, herein we reported that MPXV-1103 could elicit sustained humoral and cellular immunity in mice, including...
Saved in:
Main Authors: | Entao Li, Qiyuan Yang, Wenyu Xie, Qizan Gong, Xiaoping Guo, Jinge Zhou, Jiachen Zhang, Xia Chuai, Yucai Wang, Sandra Chiu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Emerging Microbes and Infections |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2024.2447619 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiple gene-deletion vaccinia virus Tiantan strain against mpox
by: Yilong Zhu, et al.
Published: (2025-01-01) -
An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease
by: Jianglong Li, et al.
Published: (2025-01-01) -
mRNA-LNP vaccines combined with tPA signal sequence elicit strong protective immunity against Klebsiella pneumoniae
by: Ting Huang, et al.
Published: (2025-01-01) -
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
by: Min Lin, et al.
Published: (2025-02-01) -
Nuclear mRNA export
by: Chen Suli, et al.
Published: (2024-09-01)